Exhibit 4.1


 


EXHIBIT F


 


Form of Underwriter’s Warrant


 


THE REGISTERED
HOLDER OF THIS PURCHASE WARRANT AGREES BY HIS, HER OR ITS ACCEPTANCE HEREOF, THAT SUCH HOLDER WILL NOT FOR A PERIOD OF one hundred and
eighty (180) DAYS FOLLOWING THE date of commencement of sales of the offering PURSUANT TO THE REGISTRATION STATEMENT NO.: 333-257293 AS
FILED WITH THE SECURITIES AND EXCHANGE COMMISSION: (A) SELL, TRANSFER, ASSIGN, PLEDGE OR HYPOTHECATE THIS PURCHASE WARRANT TO ANYONE
OTHER THAN (i) an underwriter or a selected dealer in connection with the offering, or (ii) bona fide OFFICERS OR PARTNERS OF
any such underwriter or selected dealer, EACH OF WHOM SHALL HAVE AGREED TO THE RESTRICTIONS CONTAINED HEREIN, IN ACCORDANCE WITH
FINRA (as defined below) CONDUCT RULE 5110(E)(1), AND (B) CAUSE THIS PURCHASE WARRANT OR THE SECURITIES ISSUABLE HEREUNDER TO
BE THE SUBJECT OF ANY HEDGING, SHORT SALE, DERIVATIVE, PUT OR CALL TRANSACTION THAT WOULD RESULT IN THE EFFECTIVE ECONOMIC DISPOSITION
OF THIS PURCHASE WARRANT OR THE SECURITIES HEREUNDER, EXCEPT AS PROVIDED FOR IN FINRA RULE 5110(E)(2).


 


THIS PURCHASE WARRANT IS NOT EXERCISABLE PRIOR
TO [•], 2021. VOID AFTER 5:00 P.M., EASTERN TIME, [•], 2026.


 


ORDINARY SHARES PURCHASE WARRANT


 


For the Purchase of [•] Ordinary Shares


 


of


 


Aspire Global Inc.


 


1.        Purchase
Warrant. THIS ORDINARY SHARES PURCHASE WARRANT (this “Purchase Warrant”) certifies that, pursuant to that certain
underwriting agreement by and between, among others, Aspire Global Inc., a Cayman Islands exempted company (the “Company”)
and US Tiger Securities, Inc. (“US Tiger”) and EF Hutton, division of Benchmark Investments, LLC (“Hutton,”
together with US Tiger, the “Representatives” and each, a “Representative”), dated [•], 2021
(the “Underwriting Agreement”), [name of holder] (in such capacity with its permitted successors or assignees, the
 “Holder”), as registered owner of this Purchase Warrant, is entitled, at any time or from time to time from [•],
2021 (the “Exercise Date”), and at or before 5:00 p.m., Eastern time, [•], 2026 (the “Expiration Date”),
but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [•] ordinary shares (the “Shares”),
par value $0.0001 per share, of the Company, subject to adjustment as provided in Section 5 hereof. If the Expiration
Date is a day on which banking institutions are authorized by law or executive order to close, then this Purchase Warrant may be exercised
on the next succeeding day which is not such a day in accordance with the terms herein. During the period commencing on the date hereof
and ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase
Warrant is initially exercisable at $[•] per Share (125% of the initial public offering price of the Shares sold in the Offering);
provided, however, that upon the occurrence of any of the events specified in Section 5 hereof, the rights granted
by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be
adjusted as therein specified. The term “Exercise Price” shall mean the exercise price in effect at the date the Exercise
Price is determined, after giving effect to any adjustment pursuant to Section 5. Any term not defined herein shall have the
meaning ascribed thereto in the Underwriting Agreement.


 






    1


     


    

 


2.        Exercise.


 


2.1        Exercise
Form. In order to exercise this Purchase Warrant, the exercise form attached hereto as Exhibit I (the “Exercise
Form”) must be duly executed and completed and delivered to the Company, together with this Purchase Warrant and payment of
the Exercise Price for the Shares being purchased payable in cash by wire transfer of immediately available funds to an account designated
by the Company or by certified check or official bank check, subject to Section 2.2 below. If the subscription rights represented
hereby shall not be exercised at or before 5:00 p.m., Eastern time, on the Expiration Date, this Purchase Warrant shall become and be
void without further force or effect, and all rights represented hereby shall cease and expire.


 


2.2        Cashless
Exercise. In lieu of exercising this Purchase Warrant by payment of cash or check payable pursuant to Section 2.1 above,
Holder may elect to receive the number of Shares equal to the value of this Purchase Warrant (or the portion thereof being exercised),
by surrender of this Purchase Warrant to the Company, together with the Exercise Form, in which event the Company shall issue to Holder,
Shares in accordance with the following formula:


 


	 	X        =	Y (A – B) 	 
	 	 	A	 


 


	Where,	X        =        The number of Shares to be issued to Holder;


 


Y        =        The
number of Shares that would be issuable upon exercise of this Purchase Warrant in accordance with the terms of this Purchase Warrant if
such exercise were by means of a cash exercise rather than a cashless exercise;


 


A        =        The fair market
value of one Share; and


 


B        =        The Exercise Price
of this Purchase Warrant in effect on the date of exercise.


 


For purposes of this Section 2.2,
the fair market value of one Share is defined as follows:


 


(i)        if
the Company’s Shares are traded on a securities exchange, the value shall be deemed to be the last sale price on such exchange on
the trading day immediately prior to the day on which the Exercise Form is submitted in connection with the exercise of this Purchase
Warrant;


 


(ii)       if
the Company’s Shares are quoted over-the-counter, the value shall be deemed to be the last sale price on the trading day immediately
prior to the day on which the Exercise Form is submitted in connection with the exercise of the Purchase Warrant; provided, that
if there is no reported sale on such date the average of the closing bid and asked prices, in each case as reported by OTC Markets Group
or its successor; or


 


(iii)      if
there is no active public market, the value shall be the fair market value thereof, as determined in good faith by the Company’s
Board of Directors.


 


2.3        Legend.
Each certificate for the securities purchased under this Purchase Warrant shall bear a legend as follows unless such securities have been
sold pursuant to a registration statement under the Securities Act of 1933, as amended (the “Act”):


 


“The securities represented by
this certificate have not been registered under the Securities Act of 1933, as amended (the “Act”), or applicable state law.
Neither the securities nor any interest therein may be offered for sale, sold or otherwise transferred except pursuant to an effective
registration statement under the Act, or pursuant to an exemption from registration under the Act and applicable state law which, in the
opinion of counsel to the Holder, reasonably satisfactory to the Company, is available.”


 






    2


     


    

 


3.        Transfer.


 


3.1        General
Restrictions. The registered Holder of this Purchase Warrant agrees by his, her or its acceptance hereof, that such Holder will not
for a period of one hundred and eighty (180) days following the date of commencement of sales of the offering (the “Commencement
Date”): (a) sell, transfer, assign, pledge or hypothecate this Purchase Warrant to anyone other than: (i) an Underwriter
or a selected dealer participating in the Offering contemplated by the Underwriting Agreement, or (ii) bona fide officers or partners
of any such Underwriter or selected dealer, each of whom shall have agreed to the restrictions contained herein, in accordance with FINRA
Rule 5110(e)(1), and (b) cause this Purchase Warrant or the securities issuable hereunder to be the subject of any hedging,
short sale, derivative, put or call transaction that would result in the effective economic disposition of this Purchase Warrant or the
securities hereunder, except as provided for in FINRA Rule 5110(e)(2). On and after the Commencement Date, transfers to others may
be made subject to compliance with or exemptions from applicable securities laws. In order to make any permitted assignment, the Holder
must deliver to the Company the assignment form attached hereto as Exhibit B duly executed and completed, together with
this Purchase Warrant and payment of all transfer taxes, if any, payable in connection therewith. The Company shall within five (5) Business
Days transfer this Purchase Warrant on the books of the Company and shall execute and deliver a new Purchase Warrant or Purchase Warrants
of like tenor to the appropriate assignee(s) expressly evidencing the right to purchase the aggregate number of Shares purchasable
hereunder or such portion of such number as shall be contemplated by any such assignment.


 


3.2        Restrictions
Imposed by the Act. The securities evidenced by this Purchase Warrant shall not be transferred unless and until: (i) the Company
has received the opinion of counsel for the Holder reasonably satisfactory to the Company that the securities may be transferred pursuant
to an exemption from registration under the Act and applicable state securities laws, or (ii) a registration statement relating to
the offer and sale of such securities that includes a current prospectus has been filed and declared effective by the Securities and Exchange
Commission (the “Commission”) and compliance with applicable state securities law has been established.


 


4.        New
Purchase Warrants to be Issued.


 


4.1        Partial
Exercise or Transfer. Subject to the restrictions in Section 3 hereof, this Purchase Warrant may be exercised
or assigned in whole or in part. In the event of the exercise or assignment hereof in part only, upon surrender of this Purchase Warrant
for cancellation, together with the duly executed exercise or assignment form (as attached hereto) and funds sufficient to pay any Exercise
Price and/or transfer tax if exercised pursuant to Section 2.1 hereof, the Company shall cause to be delivered to
the Holder without charge a new Purchase Warrant of like tenor to this Purchase Warrant in the name of the Holder evidencing the right
of the Holder to purchase the number of Shares purchasable hereunder as to which this Purchase Warrant has not been exercised or assigned.


 


4.2        Lost
Certificate. Upon receipt by the Company of evidence satisfactory to it of the loss, theft, destruction or mutilation of this Purchase
Warrant and of reasonably satisfactory indemnification or the posting of a bond, the Company shall execute and deliver a new Purchase
Warrant of like tenor and date. Any such new Purchase Warrant executed and delivered as a result of such loss, theft, mutilation or destruction
shall constitute a substitute contractual obligation on the part of the Company.


 


5.        Adjustments.


 


5.1        Adjustments
to Exercise Price and Number of Shares. The Exercise Price and the number of Shares underlying this Purchase Warrant shall be subject
to adjustment from time to time as hereinafter set forth:


 


5.1.1        Share
Dividends; Split Ups. If, after the date hereof, and subject to the provisions of Section 5.3 below, the number
of outstanding shares is increased by a stock dividend payable in Shares or by a split up of Shares or other similar event, then, on the
effective day thereof, the number of Shares purchasable hereunder shall be increased in proportion to such increase in outstanding shares,
and the Exercise Price shall be proportionately decreased.


 


5.1.2        Aggregation
of Shares. If, after the date hereof, and subject to the provisions of Section 5.3 below, the number of outstanding
shares is decreased by a consolidation, combination, reverse stock split or reclassification of shares or other similar event, then, on
the effective date thereof, the number of Shares purchasable hereunder shall be decreased in proportion to such decrease in outstanding
shares, and the Exercise Price shall be proportionately increased.


 






    3


     


    

 


5.1.3        Replacement
of Shares upon Reorganization, etc. In case of any reclassification or reorganization of the outstanding shares other than a
change covered by Section 5.1.1 or Section 5.1.2 hereof or that solely affects the par value
of such shares, or in the case of any share reconstruction or amalgamation or consolidation of the Company with or into another corporation
(other than a consolidation or share reconstruction or amalgamation in which the Company is the continuing corporation and that does not
result in any reclassification or reorganization of the outstanding shares), or in the case of any sale or conveyance to another corporation
or entity of the property of the Company as an entirety or substantially as an entirety in connection with which the Company is dissolved,
the Holder of this Purchase Warrant shall have the right thereafter (until the expiration of the right of exercise of this Purchase Warrant)
to receive upon the exercise hereof, for the same aggregate Exercise Price payable hereunder immediately prior to such event, the kind
and amount of shares of stock or other securities or property (including cash) receivable upon such reclassification, reorganization,
share reconstruction or amalgamation, or consolidation, or upon a dissolution following any such sale or transfer, by a Holder of the
number of Shares of the Company obtainable upon exercise of this Purchase Warrant immediately prior to such event; and if any reclassification
also results in a change in Shares covered by Section 5.1.1 or Section 5.1.2, then such adjustment
shall be made pursuant to Section 5.1.1, Section 5.1.2 and this Section 5.1.3.
The provisions of this Section 5.1.3 shall similarly apply to successive reclassifications, reorganizations, share
reconstructions or amalgamations, or consolidations, sales or other transfers.


 


5.1.4        Changes
in Form of Purchase Warrant. This form of Purchase Warrant need not be changed because of any change pursuant to this Section 5.1,
and Purchase Warrants issued after such change may state the same Exercise Price and the same number of Shares as are stated in the Purchase
Warrants initially issued pursuant to this Agreement. The acceptance by any Holder of the issuance of new Purchase Warrants reflecting
a required or permissive change shall not be deemed to waive any rights to an adjustment occurring after the date hereof or the computation
thereof.


 


5.2        Substitute
Purchase Warrant. In case of any consolidation of the Company with, or share reconstruction or amalgamation of the Company with or
into, another corporation (other than a consolidation or share reconstruction or amalgamation which does not result in any reclassification
or change of the outstanding Shares), the corporation formed by such consolidation or share reconstruction or amalgamation shall execute
and deliver to the Holder an amendment to this Purchase Warrant that provides that the Holder of this Purchase Warrant, to the extent
outstanding, shall have the right thereafter (until the stated expiration of this Purchase Warrant) to receive, upon exercise of such
Purchase Warrant, the kind and amount of shares of stock and other securities and property receivable upon such consolidation or share
reconstruction or amalgamation, by a Holder of the number of Shares of the Company or other securities of the successor to the Company,
as the case may be, for which such Purchase Warrant might have been exercised immediately prior to the effective time of such consolidation,
share reconstruction or amalgamation, sale or transfer. Such amendment to this Purchase Warrant shall provide for adjustments which shall
be identical to the adjustments provided for in this Section 5. The above provision of this Section 5 shall
similarly apply to successive consolidations or share reconstructions or amalgamations.


 


5.3        Elimination
of Fractional Interests. The Company shall not be required to issue certificates representing fractions of Shares upon the exercise
of the Purchase Warrant. As to any fraction of a Share which the Holder would otherwise be entitled to purchase upon such exercise, the
Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the fair market value as of the date of exercise pursuant to Section 2.1 or Section 2.2, as applicable, or
round up to the next whole Share.


 


6.        Registration
Rights. The Company has filed the Registration Statement on Form F-1 (File No. 333-257293) with the Commission, which has
been declared effective, and registers the underlying Shares of the Purchase Warrant(s) granted to the Holder(s) in connection
with the Offering, under the terms of the Underwriting Agreement.


 


6.1        Demand
Registration.


 


6.1.1        Grant
of Right. Unless all of the Registrable Securities (defined as below) are included in an effective registration statement with a current
prospectus, the Company, upon written demand (“Demand Notice”) of the Holder(s) of at least 51% of the Purchase
Warrants and/or the underlying securities (“Majority Holder(s)”), agrees to register on up to two occasions, all or
any portion of the Shares underlying the Purchase Warrants (collectively, the “Registrable Securities”) as requested
by the Majority Holder(s) in the Demand Notice (each such registration, a “Demand Registration”). On each such
occasion, the Company will file a new registration statement or a post-effective amendment to the Registration Statement covering the
Registrable Securities within sixty (60) days after receipt of the Demand Notice and use its best efforts to have such registration statement
or post-effective amendment declared effective as soon as possible thereafter. The demand for registration may be made at any time after
the Commencement Date, but no later than five (5) years therefrom. The Company covenants and agrees to give written notice of its
receipt of any Demand Notice by any Holder(s) to all other registered Holders of the Underwriter’s Warrants and/or the Registrable
Securities within ten (10) days from the date of the receipt of any such Demand Notice, who shall have five (5) days from the
receipt of such Notice in which to notify the Company of their desire to have their Registrable Securities included in the registration
statement.


 






    4


     


    

 


6.1.2        Terms.
The Company shall bear all fees and expenses attendant to registering the Registrable Securities upon the first Demand Notice, including
the reasonable expenses of any legal counsel selected by the Holders to represent them in connection with the sale of the Registrable
Securities, but the Holders shall pay any and all underwriting or brokerage commissions and other selling expenses, if any. The Holders
shall bear all fees and expenses attendant to registering the Registrable Securities upon the second Demand Notice, if any. The Company
agrees to use its best efforts to cause any filings required herein to become effective as promptly as possible and to qualify or register
the Registrable Securities in such States as are reasonably requested by the Majority Holder(s); provided, however, that in no event shall
the Company be required to register the Registrable Securities in a State in which such registration would cause (i) the Company
to be obligated to qualify to do business in such State or execute a general consent to service of process, or (ii) the principal
shareholders of the Company to be obligated to escrow their shares of the Company. The Company shall cause any registration statement
or post-effective amendment filed pursuant to the demand rights granted under Section 6.1.1 to remain effective for a period
of twelve (12) consecutive months from the effective date of such registration statement or post-effective amendment or until the Holders
have completed the distribution of the Registrable Securities included in such registration statement, whichever occurs first.


 


6.2          “Piggy-Back”
Registration.


 


6.2.1        Grant
of Right. Unless all of the Registrable Securities are included in an effective registration statement with a current prospectus,
the Holders of the Underwriter’s Warrants shall have the right for a period of not more than five (5) years from the Commencement
Date, to include the remaining Registrable Securities as part of any other registration of securities filed by the Company (other than
in connection with a transaction contemplated by Rule 145(a) promulgated under the Act or pursuant to Form S-8 or F-4 or
S-4 or any successor or equivalent form); provided, however, that if, in the opinion of the Company’s managing underwriters or underwriters,
if any, for such offering, the inclusion of the Registrable Securities, when added to the securities being registered by the Company or
the selling shareholder(s), will exceed the maximum amount of the Company’s securities which can be marketed (i) at a price
reasonably related to their then current market value, and (ii) without materially and adversely affecting the entire offering, then
the Company will still be required to include the Registrable Securities, but may require the Holders to agree, in writing, to delay the
sale of all or any portion of the Registrable Securities for a such period, not to exceed one hundred eighty (180) days from the effective
date of the offering as the managing underwriters or underwriters may require, provided, further, that if the sale of any Registrable
Securities is so delayed, then the number of securities to be sold by each Holder of the Registrable Securities in such public offering
shall be made pro rata among them, in proportion to the total amount of securities of the Company owned by said Holders seeking to include
Registrable Securities; provided, however, that the Company shall not exclude any Registrable Securities unless the Company has first
excluded all outstanding securities, the holders of which are not entitled to inclusion of such securities in such registration statement
or are not entitled to pro rata inclusion with the Registrable Securities.


 


6.2.2        Terms.
The Company shall bear all fees and expenses attendant to registering the Registrable Securities, including the expenses of any legal
counsel selected by the Holders to represent them in connection with the sale of the Registrable Securities, but the Holders shall pay
any and all underwriting or brokerage commissions and other selling expenses, if any. In the event of such a proposed registration, the
Company shall furnish the then Holders of outstanding Registrable Securities with not less than ten (10) days written notice prior
to the proposed date of filing of such registration statement. Such notice to the Holders shall continue to be given for each applicable
registration statement filed (during the period in which the Underwriter’s Warrant is exercisable) by the Company until such time
as all of the Registrable Securities have been registered and sold. The Holders of the Registrable Securities shall exercise the “piggy
back” rights provided for herein by giving written notice, within seven (7) business days of the receipt of the Company’s
notice of its intention to file a registration statement. The Company shall use its best efforts to cause any registration statement filed
pursuant to the above “piggyback” rights that does not relate to a firm commitment underwritten offering to remain effective
for at least nine (9) consecutive months from the effective date of such registration statement or until the Holders have completed
the distribution of the Registrable Securities in the registration statement, whichever occurs first. Except as otherwise provided in
this Purchase Warrant, there shall be no limit on the number of times the Holders may request registration under this Section 6.2.2.


 






    5


     


    

 


6.3         General
Terms.


 


6.3.1         Indemnification.
The Company shall indemnify the Holder(s) of the Registrable Securities to be sold pursuant to any registration statement hereunder
and each person, if any, who controls such Holders within the meaning of Section 15 of the Act or Section 20(a) of the
Securities Exchange Act of 1934, as amended (“Exchange Act”), against all loss, claim, damage, expense or liability
(including all reasonable attorneys’ fees and other expenses reasonably incurred in investigating, preparing or defending against
any claim whatsoever) to which any of them may become subject under the Act, the Exchange Act or otherwise, arising from such registration
statement but only to the same extent and with the same effect as the provisions pursuant to which the Company has agreed to indemnify
the Underwriters contained in Section 7(a) of the Underwriting Agreement. The Holder(s) of the Registrable Securities to
be sold pursuant to such registration statement, and their successors and assignees, shall severally, and not jointly, indemnify the Company,
against all loss, claim, damage, expense or liability (including all reasonable attorneys’ fees and other expenses reasonably incurred
in investigating, preparing or defending against any claim whatsoever) to which they may become subject under the Act, the Exchange Act
or otherwise, arising from information furnished by or on behalf of such Holder(s), or their successors or assigns, in writing, for specific
inclusion in such registration statement to the same extent and with the same effect as the provisions contained in Section 7(b) of
the Underwriting Agreement.


 


6.3.2         Exercise
of Purchase Warrants. Nothing contained in this Purchase Warrant shall be construed as requiring the Holder(s) to exercise their
Purchase Warrants prior to or after the initial filing of any registration statement or the effectiveness thereof.


 


6.3.3         Documents
Delivered to Holders. The Company shall deliver as promptly as possible to each Holder participating in the offering and to the managing
underwriter(s), if any, upon request of the Holder, the following correspondence and memoranda relating to the offering: copies of all
correspondence between the Commission and the Company, its counsel or auditors and all memoranda relating to discussions with the Commission
or its staff with respect to the registration statement. The Company shall permit each Holder and the underwriter(s), if any, to do such
investigation upon reasonable advance notice, with respect to information contained in or omitted from the registration statement as it
deems reasonably necessary to comply with applicable securities laws or rules of FINRA. Such investigation shall include access to
books, records and properties and opportunities to discuss the business of the Company with its officers and independent auditors, all
to such reasonable extent and at such reasonable times as any such Holder shall reasonably request in connection with the underwritten
offering.


 


6.3.4         [reserved]


 


6.3.5         Documents
to be Delivered by Holder(s). It shall be a condition precedent to the obligations of the Company to complete any registration pursuant
to this Section 6 that each Holder participating in the Offering shall furnish to the Company in a timely manner such information
regarding such Holder, the Registrable Securities held by it and the intended method of disposition of the Registrable Securities held
by it as shall be reasonably required to effect and maintain the effectiveness of the registration of such Registrable Securities and
shall execute such documents in connection with such registration as the Company may reasonably request In furtherance of the foregoing,
each of the Holder(s) participating in any of the foregoing offerings shall furnish to the Company a completed and executed questionnaire
provided by the Company requesting information customarily sought of selling security holders.


 






    6


     


    

 


6.3.6         Damages.
Should the registration or the effectiveness thereof required by Section 6.1 and Section 6.2 hereof be delayed
by the Company or the Company otherwise fail to comply with such provisions, the Holder(s) shall, in addition to any other legal
or other relief available to the Holder(s), be entitled to obtain specific performance or other equitable (including injunctive) relief
against the threatened breach of such provisions or the continuation of any such breach, without the necessity of proving actual damages
and without the necessity of posting bond or other security.


 


7.        Reservation
and Listing. The Company shall at all times reserve and keep available out of its authorized Shares, solely for the purpose of issuance
upon exercise of this Purchase Warrant, such number of Shares or other securities, properties or rights as shall be issuable upon the
exercise thereof. The Company covenants and agrees that, upon exercise of this Purchase Warrant and payment of the Exercise Price therefor,
in accordance with the terms hereby, all Shares and other securities issuable upon such exercise shall be duly and validly issued, fully
paid and non-assessable and not subject to preemptive rights of any shareholder. As long as this Purchase Warrant shall be outstanding,
the Company shall use its best efforts to cause all Shares issuable upon exercise of this Purchase Warrant to be listed (subject to official
notice of issuance) on a national securities exchange (or, if applicable, on the OTC Bulletin Board or any successor trading market) on
which the Shares issued to the public in the offering may then be listed and/or quoted.


 


8.        Certain
Notice Requirements.


 


8.1        Holder’s
Right to Receive Notice. Nothing herein shall be construed as conferring upon the Holders the right to vote or consent or to receive
notice as a shareholder for the election of directors or any other matter, or as having any rights whatsoever as a shareholder of the
Company. If, however, at any time prior to the expiration of the Purchase Warrants and their exercise, any of the events described in Section 8.2 shall
occur, then, in one or more of said events, the Company shall give written notice of such event at least fifteen (15) days prior to the
date fixed as a record date or the date of closing the transfer books (the “Notice Date”) for the determination of
the shareholders entitled to such dividend, distribution, conversion or exchange of securities or subscription rights, or entitled to
vote on such proposed dissolution, liquidation, winding up or sale. Such notice shall specify such record date or the date of the closing
of the transfer books, as the case may be. Notwithstanding the foregoing, the Company shall deliver to each Holder a copy of each notice
given to the other shareholders of the Company at the same time and in the same manner that such notice is given to the shareholders.


 


8.2        Events
Requiring Notice. The Company shall be required to give the notice described in this Section 8 upon one or more
of the following events: (i) if the Company shall take a record of the holders of its shares for the purpose of entitling them to
receive a dividend or distribution payable otherwise than in cash, or a cash dividend or distribution payable otherwise than out of retained
earnings, as indicated by the accounting treatment of such dividend or distribution on the books of the Company, (ii) the Company
shall offer to all the holders of its shares any additional shares of capital stock of the Company or securities convertible into or exchangeable
for shares of capital stock of the Company, or any option, right or warrant to subscribe therefor, or (iii) a dissolution, liquidation
or winding up of the Company (other than in connection with a consolidation or share reconstruction or amalgamation) or a sale of all
or substantially all of its property, assets and business shall be proposed.


 


8.3        Notice
of Change in Exercise Price. The Company shall, promptly after an event requiring a change in the Exercise Price pursuant to Section 5 hereof,
send notice to the Holders of such event and change (“Price Notice”). The Price Notice shall describe the event causing
the change and the method of calculating same and shall be certified as being true and accurate by the Company’s Chief Financial
Officer.


 


8.4        Transmittal
of Notices. All notices, requests, consents and other communications under this Purchase Warrant shall be in writing and shall be
deemed to have been duly made (1) when hand delivered, (2) when mailed by express mail or private courier service, (3) if
sent by electronic mail, on the day the notice was sent if during regular business hours and, if sent outside of regular business hours,
on the following business day, or (4) when the event requiring notice is disclosed in all material respects and filed in a Current
Report on Form 6-K prior to the Notice Date: (i) if to the registered Holder of the Purchase Warrant, to the address of such
Holder as shown on the books of the Company, or (ii) if to the Company, to following address or to such other address as the Company
may designate by notice to the Holders:


 






    7


     


    

 


If to the Holder:


 


US
Tiger Securities, Inc.


437 Madison Ave.,
27th Floor


New York, NY 10022


Attention: Lei Huang


Email: Project_ag@ustigersecurities.com


 


with a copy (which shall not constitute notice)
to:


 


Sidley Austin LLP


39/F, Two Int’l
Finance Centre


Central, Hong Kong


Attention: Meng
Ding, Esq.


Email: meng.ding@sidley.com


 


If sent to the Company, shall be mailed,
delivered, or emailed, to the Company:


 


Aspire Global Inc.


14 Jian’an
Road


Tangwei Fuyong
Town


Bao’an District,
Shenzhen


Guangdong Province,
China


Attention: Michael
Wang, CFO


Email: michael@getispire.com


 


with a copy (which shall not constitute notice)
to the Company’s Counsel at


:


Ellenoff Grossman &
Schole LLP


1345 Avenue of
the Americas, 11th Floor


New York, NY 10105


Attention: Richard
I. Anslow, Esq.


Email: ranslow@egsllp.com


 


9.        Miscellaneous.


 


9.1        Amendments.
The Company and the Representatives may from time to time supplement or amend this Purchase Warrant without the approval of any of the
Holders in order to cure any ambiguity, to correct or supplement any provision contained herein that may be defective or inconsistent
with any other provisions herein, or to make any other provisions in regard to matters or questions arising hereunder that the Company
and Representatives may deem necessary or desirable and that the Company and the Representatives deem shall not adversely affect the interest
of the Holders. All other modifications or amendments shall require the written consent of and be signed by the party against whom enforcement
of the modification or amendment is sought.


 


9.2        Headings.
The headings contained herein are for the sole purpose of convenience of reference, and shall not in any way limit or affect the meaning
or interpretation of any of the terms or provisions of this Purchase Warrant.


 


9.3        Entire
Agreement. This Purchase Warrant (together with the other agreements and documents being delivered pursuant to or in connection with
this Purchase Warrant to the extent provided in this Purchase Warrant) constitutes the entire agreement of the parties hereto with respect
to the subject matter hereof, and supersedes all prior agreements and understandings of the parties, oral and written, with respect to
the subject matter hereof.


 


9.4        Binding
Effect. This Purchase Warrant shall inure solely to the benefit of and shall be binding upon, the Holder and the Company and their
permitted assignees and respective successors and no other person shall have or be construed to have any legal or equitable right, remedy
or claim under or in respect of or by virtue of this Purchase Warrant or any provisions herein contained.


 






    8


     


    

 


9.5        Governing
Law; Submission to Jurisdiction. This Purchase Warrant shall be governed by and construed and enforced in accordance with the laws
of the State of New York, without giving effect to conflict of laws principles thereof. The Company hereby agrees that any action, proceeding
or claim against it arising out of, or relating in any way to this Purchase Warrant shall be brought and enforced in the Borough of Manhattan
in The City of New York (each, a “New York Court”), and irrevocably submits to such jurisdiction, which jurisdiction
shall be exclusive. Each of the Holder and the Company hereby waives any objection to such exclusive jurisdiction and that such courts
represent an inconvenient forum. Any process or summons to be served upon the Company or the Holder may be served by transmitting a copy
thereof by registered or certified mail, return receipt requested, postage prepaid, addressed to it at their respective addresses set
forth in Section 8.4 hereof. Such mailing shall be deemed personal service and shall be legal and binding upon the
Company or the Holder in any action, proceeding or claim.


 


9.6        Waiver, etc.
The failure of the Company or the Holder to at any time enforce any of the provisions of this Purchase Warrant shall not be deemed or
construed to be a waiver of any such provision, nor to in any way affect the validity of this Purchase Warrant or any provision hereof
or the right of the Company or any Holder to thereafter enforce each and every provision of this Purchase Warrant. No waiver of any breach,
non-compliance or non-fulfillment of any of the provisions of this Purchase Warrant shall be effective unless set forth in a written instrument
executed by the party or parties against whom or which enforcement of such waiver is sought; and no waiver of any such breach, non-compliance
or non-fulfillment shall be construed or deemed to be a waiver of any other or subsequent breach, non-compliance or non-fulfillment.


 


9.7        Exchange
Agreement. As a condition of the Holder’s receipt and acceptance of this Purchase Warrant, Holder agrees that, at any time prior
to the complete exercise of this Purchase Warrant by Holder, if the Company and the Representatives (to the extent that they and their
affiliates (as defined by the United States securities laws) are Holders of Purchase Warrants) enter into an agreement (“Exchange
Agreement”) pursuant to which they agree that all outstanding Purchase Warrants will be exchanged for securities or cash or
a combination of both, then Holder shall agree to such exchange and become a party to the Exchange Agreement.


 


9.8        [Reserved]


 


9.9        Restrictions.
The Holder acknowledges that the Shares acquired upon the exercise of this Purchase Warrant, if not registered, and if the Holder does
not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.


 


9.10        Severability.
Wherever possible, each provision of this Purchase Warrant shall be interpreted in such manner as to be effective and valid under applicable
law, but if any provision of this Purchase Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective
to the extent of such prohibition or invalidity, without invalidating the remainder of such provision or the remaining provisions of this
Purchase Warrant.


 


[ Remainder of Page Intentionally Left
Blank ]


 






    9


     


    

 


IN
WITNESS WHEREOF, the Company has caused this Purchase Warrant to be signed by its duly authorized officer as of the ____ day
of _______, 2021.


 


	Aspire Global Inc.	 
	 	 	 
	 	 	 
	By:	 	 
	 	Name: Tuanfang Liu	 
	 	Title:   Chief Executive Officer	 



 






    10


     


    

 


EXHIBIT I


EXERCISE FORM


 


Form to be used to exercise Purchase Warrant:


 


Date: __________, 20_____


 


The undersigned hereby elects
irrevocably to exercise the Purchase Warrant for ______ordinary shares (the “Shares”) of Aspire Global Inc., a Cayman
Islands exempted company (the “Company”) and hereby makes payment of $____ (at the price of $____ per Share) in payment
of the Exercise Price pursuant thereto. Please issue the Shares as to which this Purchase Warrant is exercised in accordance with the
instructions given below and, if applicable, a new Purchase Warrant representing the number of Shares for which this Purchase Warrant
has not been exercised.


 


or


 


The undersigned hereby elects
irrevocably to convert its right to purchase ___ Shares under the Purchase Warrant for ______ Shares, as determined in accordance with
the following formula:


 


	 	X         =	Y(A-B)
	 	 	A
	 	Where,	 
	 	 	 	 


 


X        =        The number of Shares
to be issued to Holder;


 


Y        =        The number of Shares
that would be issuable upon exercise of this Purchase Warrant in accordance with the terms of this Purchase Warrant if such exercise were
by means of a cash exercise rather than a cashless exercise;


 


A        =        The fair market value
of one Share; and


 


B        =        The Exercise Price of
this Purchase Warrant in effect on the date of exercise


 


The undersigned agrees and
acknowledges that the calculation set forth above is subject to confirmation by the Company and any disagreement with respect to the calculation
shall be resolved by the Company in its sole discretion.


 


Please issue the Shares as
to which this Purchase Warrant is exercised in accordance with the instructions given below and, if applicable, a new Purchase Warrant
representing the number of Shares for which this Purchase Warrant has not been exercised.


 


Signature:


 


Signature Guaranteed:


 


INSTRUCTIONS FOR REGISTRATION OF SECURITIES


 


Name:


(Print in Block Letters)


 


Address:


 


NOTICE: The signature to
this form must correspond with the name as written upon the face of the Purchase Warrant without alteration or enlargement or any change
whatsoever, and must be guaranteed by a bank, other than a savings bank, or by a trust company or by a firm having membership on a registered
national securities exchange.


 






    11


     


    

 


EXHIBIT II


ASSIGNMENT FORM


 


Form to be used to assign Purchase Warrant:


 


(To be executed by the registered
Holder to effect a transfer of the within Purchase Warrant):


 


FOR VALUE RECEIVED,                                                                                  does
hereby sell, assign and transfer unto the right to purchase ordinary shares of Aspire Global Inc., a Cayman Islands exempted company (the
 “Company”), evidenced by the Purchase Warrant and does hereby authorize the Company to transfer such right on the books
of the Company to


 


_______________________________________________
whose address is


 


_______________________________________________________________.


 


_______________________________________________________________


 


Dated:  ____________, 20__


 


	 	Holder’s Signature: 	 	 
	 	 	 	 
	 	Holder’s Address:  	 	 
	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 
	 	Signature Guaranteed: 	 	 



 


NOTICE: The signature to this
form must correspond with the name as written upon the face of the within Purchase Warrant without alteration or enlargement or any change
whatsoever, and must be guaranteed by a bank or trust company. Officers of corporations and those acting in a fiduciary or other representative
capacity should file proper evidence of authority to assign the foregoing Purchase Warrant.


 






    12